Sunday 11 October 2026 Export all EQ data to Excel Powerpack

Equillium, Inc.

EQ Healthcare Biotechnology

Equillium, Inc.’s revenue for fiscal 2024 (year ended December 2024) was $41.1 million, up 13.9% from fiscal 2023. In the quarter to June 2026, revenue fell 52.3%, EPS grew 75.0% and free cash flow fell 38.7%, each against the same quarter a year earlier. Dividend growth for three consecutive years, revenue growth for three.

1.41 0.03 −2.08%
Market cap
$91.3M
P/E
0.0×
Fwd P/E
−5.2×
Dividend yield
—
F-score
3/9
Altman Z
−6.75
Beneish M
n/a
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
P/E ratio

+8 more quarters

— — — —
EV/Sales
— — — —
EV/FCF
— — — —
Quick Ratio
10.70 10.32 18.33 23.07
Current Ratio
10.85 10.58 18.62 23.40
Net Debt/EBITDA
7.28 7.69 10.98 11.15
Debt/Assets
0.00% 0.00% 0.00% 0.00%
Debt/Equity
0.00 0.00 0.00 0.00
Asset Turnover
0.00 0.00 0.00 0.00
Operating CF/Net income
1.99 0.83 0.81 0.88
Capex/Depreciation
0.00 (1.39) (0.12) (2.73)
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
0.00% 0.00% 0.00% 0.00%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00
Share Based Compensation of Revenue
0.00% 0.00% 0.00% 0.00%
Free Cash Flow Yield
— — — —
Revenue per Share
0.00 0.00 0.00 0.00
Operating CF per Share
(0.13) (0.05) (0.04) (0.04)
Capex per Share
0.00 0.00 0.00 0.00
Free Cash Flow per Share
(0.13) (0.06) (0.04) (0.04)
Cash per Share
0.51 0.53 0.64 0.51
Shareholders Equity per Share
0.47 0.50 0.62 0.50
Interest Debt per Share
0.00 0.00 0.00 0.00
Book value per Share
0.47 0.50 0.62 0.50
Free Cash Flow
(8.43) (3.16) (4.30) (4.18)
Working Capital
30.49 28.10 58.93 55.50
Capital Expenditures
0.00 (0.03) 0.00 (0.07)
Net Current Asset Value
30.01 27.75 58.68 55.33
EV/EBIT
— — — —
Capex to Sales
0.00 0.00 0.00 0.00
Other line items
Average Payables
2.37 1.72 2.18 2.83
Average Assets
34.48 28.75 39.91 35.53
Average Common Equity
27.06 23.83 35.03 30.54

Fold the line items

Columns are period end dates